Globalink Investment Approves Merger with Alps Life Sciences
Globalink Investment Inc. (GLLI) has received stockholder approval for a merger with Alps Life Sciences Inc. during a special meeting on October 7, 2025. This includes a Redomestication Merger and an Acquisition Merger, enhancing Globalink's market position. Stockholders also approved an amendment to remove the net tangible asset requirement, aiding the merger's completion. Globalink focuses on mergers and acquisitions in the investment industry, with a current market cap of $52.76M and an average trading volume of 2,447 shares.
Globalink Investment Inc. ( (GLLI) ) has shared an update.
On October 7, 2025, Globalink Investment Inc. held a special meeting where stockholders approved several proposals related to a business combination with Alps Life Sciences Inc. This includes the Redomestication Merger, where Globalink will merge with Alps Global Holding Pubco, and the Acquisition Merger, where Alps will become a wholly-owned subsidiary of PubCo. The approval of these proposals signifies a strategic move to strengthen Globalink’s market position and operational capabilities. Additionally, stockholders approved an amendment to eliminate the net tangible asset requirement, facilitating the completion of the business combination, while a number of public shares were redeemed for cash.
More about Globalink Investment Inc.
Globalink Investment Inc. operates in the investment industry, focusing on mergers and acquisitions to expand its market presence and enhance its portfolio.
Average Trading Volume: 2,447
Technical Sentiment Signal: Buy
Current Market Cap: $52.76M
